- Home
- MSLE vs WHF Comparison
MSLE vs WHF Comparison
Compare MSLE & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MSLE | WHF |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 152.5M |
| IPO Year | 2007 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MSLE | WHF |
|---|---|---|
| Price | $7.46 | $7.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $25.80 | $7.83 |
| AVG Volume (30 Days) | 56.7K | ★ 101.0K |
| Earning Date | 11-15-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 14.87% |
| EPS Growth | N/A | ★ 31.91 |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.38 |
| P/E Ratio | ★ N/A | $15.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.44 | $6.07 |
| 52 Week High | $13.39 | $7.84 |
Technical Indicators
Market Signals| Indicator | MSLE | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 31.26 | 48.97 |
| Support Level | $6.71 | $6.85 |
| Resistance Level | $10.58 | $7.22 |
| Average True Range (ATR) | 0.56 | 0.18 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 9.62 | 46.14 |
Price Performance
Historical ComparisonAbout MSLE Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.